bpc-157 fda status united states 83% of peptide-aware Americans want the to make peptides more accessible 🚨 FDA PEPTIDE PANEL VOTES

FDA PEPTIDE PANEL VOTES 'YES' ON BPC 157 8 YES 6 NO 1 ABSTAIN $HIMS The future of peptides in the US is about to become clearer. Here's what you should know CNN A step towards expanded patient access. This will allow patients to have conversations about these compounds in the clinical setting instead of resorting to a gray market without practitioner oversight or monitoring! FDA panel backs broader access to BPC 157, opening scrutiny on peptide market

SKU: 72188645794 · From iglepidom.org